-
1Academic Journal
المؤلفون: Yu Jiang, Yang Liu, Nian Liu, Shize Qin, Shuting Zhong, Xiaohua Huang
المصدر: International Journal of Hyperthermia, Vol 41, Iss 1 (2024)
مصطلحات موضوعية: Caesarean scar pregnancy, high-intensity focused ultrasound, suction curettage, clinical efficacy, safety, favourable reproductive outcomes, Medical technology, R855-855.5
وصف الملف: electronic resource
-
2Academic Journal
المؤلفون: Jakab Radomír
المصدر: EU agrarian Law, Vol 13, Iss 1, Pp 1-8 (2024)
مصطلحات موضوعية: right to a favourable environment, legislation, municipalities, Agriculture (General), S1-972, Environmental law, K3581-3598
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1339-9276
-
3Academic Journal
المؤلفون: Dan-Mihai ROHOZNEANU
المصدر: Studia Universitatis Babeş-Bolyai: Educatio Artis Gymnasticae, Vol 69, Iss 3 (2024)
مصطلحات موضوعية: handball, favourable context, evolution, performances, Special aspects of education, LC8-6691, Sports, GV557-1198.995
وصف الملف: electronic resource
-
4Academic Journal
المؤلفون: Takuro Hamaguchi, Toru Takiguchi, Tomohisa Seki, Naoki Tominaga, Jun Nakata, Takeshi Yamamoto, Takashi Tagami, Akihiko Inoue, Toru Hifumi, Tetsuya Sakamoto, Yasuhiro Kuroda, Shoji Yokobori, the SAVE-J II study group
المصدر: Annals of Intensive Care, Vol 14, Iss 1, Pp 1-10 (2024)
مصطلحات موضوعية: Extracorporeal cardiopulmonary resuscitation, Favourable neurological outcome, Out-of-hospital cardiac arrest, Pupillary examination, Medical emergencies. Critical care. Intensive care. First aid, RC86-88.9
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2110-5820
-
5Academic Journal
المؤلفون: John McGrane, Ricky Frazer, Amarnath Challapalli, Gihan Ratnayake, Zhaung Boh, Alison Clayton, Caroline Chau, Anand Sharma, Manal Elgendy, Natalie Charnley, Wael Mohamed, Sarah Kingdon, Andrew Protheroe, Anna Lydon, Anna Halstead, Vicky Ford, Iqtedar Muazzam, Dawn Lee, G. J. Melendez‐Torres, Amit Bahl
المصدر: Cancer Medicine, Vol 13, Iss 12, Pp n/a-n/a (2024)
مصطلحات موضوعية: favourable risk, immunotherapy, overall survival, renal cell carcinoma, Neoplasms. Tumors. Oncology. Including cancer and carcinogens, RC254-282
وصف الملف: electronic resource
Relation: https://doaj.org/toc/2045-7634
-
6Academic Journal
المؤلفون: Maosheng Zheng, Jie Yu
المصدر: Tehnički Glasnik, Vol 18, Iss 3, Pp 337-341 (2024)
مصطلحات موضوعية: favourable probability,
"intersection, material processing, optimization of many objectives, scheme selection, Technology وصف الملف: electronic resource
-
7Academic Journal
المؤلفون: David Romero, Raúl Maneyro, José Carlos Guerrero, Raimundo Real
المصدر: Frontiers in Zoology, Vol 20, Iss 1, Pp 1-15 (2023)
مصطلحات موضوعية: Amphibians, Incomplete records, Favourable areas, Fuzzy consensus, Non-observed species, Potential biodiversity, Zoology, QL1-991
وصف الملف: electronic resource
Relation: https://doaj.org/toc/1742-9994
-
8Academic Journal
المؤلفون: J Wang, S Vordenbäumen, M Schneider, R Brinks
مصطلحات موضوعية: Medicine, Biotechnology, Ecology, Immunology, Developmental Biology, Cancer, Science Policy, Infectious Diseases, Computational Biology, Environmental Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, underscoring impending challenges, statutory health insurance, old age group, models robustly support, improving treatment effectiveness, german central institute, future prediction analysis, 70 – 80, based epidemiological projections, particularly among women, 417 000 cases, 179 000 cases, least favourable scenario, estimate future numbers, 2040 . p, favourable scenario, 284 000, based projection, peak numbers
-
9Academic Journal
المؤلفون: Pingchang Sun, Wangpeng Li, Zhaojun Liu, Daming Niu, Xiaoling Wu, Lianxin Tao, Zhuo Wang, Zhisheng Luan
المصدر: Oil Shale, Vol 40, Iss 3, Pp 177-193 (2023)
مصطلحات موضوعية: chinese oil shale, in-situ conversion, favourable targets, geological parameters, fushun, bagemaode, Technology, Science (General), Q1-390
وصف الملف: electronic resource
-
10Academic Journal
المؤلفون: Olivier GEFFROY, Tracey Siebert, Emilie Guyot, Florence Gazagnadou, Aude Henon, Thomas Baerenzung dit Baron, Marie Denat, Christian Chervin, Markus Herderich, Eleanor Bilogrevic, María Pilar Sáenz-Navajas
المصدر: OENO One, Vol 58, Iss 1 (2024)
مصطلحات موضوعية: rotundone, peppery notes, conceptualisation, favourable conditions, Northern Rhone valley, Languedoc Roussillon, Agriculture, Botany, QK1-989
وصف الملف: electronic resource
-
11Academic Journal
المؤلفون: Rajalakshmi, S.
المصدر: International Journal of Science and Social Science Research, 1(4), 49-52, (2024-01-08)
مصطلحات موضوعية: Law, personality of the criminal, favourable social environment, sanction, socialization, punishment, prevention, deviant behaviour, delinquency, teenager, crime, Criminal Law and Criminal Justice Administration
Relation: https://zenodo.org/communities/ijsssr; https://doi.org/10.5281/zenodo.13362459; https://doi.org/10.5281/zenodo.13362460; oai:zenodo.org:13362460
-
12Academic Journal
المؤلفون: I Made Sudarma, Ni Nengah Darmiati, Dewa Ngurah Suprapta
المصدر: GPH-International Journal of Agriculture and Research, 07(04), 50-60, (2024-05-26)
مصطلحات موضوعية: suppressive soil, conducive soil, biocontrol, favourable condition, and microbes, Agriculture and Research
Relation: https://doi.org/10.5281/zenodo.11311629; https://doi.org/10.5281/zenodo.11311630; oai:zenodo.org:11311630; https://gphjournal.org/index.php/ar/article/view/1354
-
13Academic Journal
المؤلفون: Sempebwa Brian, Daniel Abraham, Bukira Germina, Tumusiime Jazzilah, Nambusi Aidah, Baseka Hamidah, Mwanja Paul
المصدر: INTERNATIONAL CONFERENCE ON ADVANCE SCIENCE AND TECHNOLOGY, 1(1), 5-9, (2024-01-04)
مصطلحات موضوعية: Culture, International Business, Polychronic, Corruption. Introduction Sub-Saharan Africa which currently consist of forty-eight countries, endowed with minerals, favourable climate and good soils for agriculture
Relation: https://doi.org/10.5281/zenodo.10459193; https://doi.org/10.5281/zenodo.10459194; oai:zenodo.org:10459194
-
14Academic Journal
المؤلفون: Geffroy, Olivier, Siebert, Tracey, Guyot, Emilie, Gazagnadou, Florence, Henon, Aude, Baron, Thomas Baerenzung Dit, Denat, Marie, Chervin, Christian, Herderich, Markus, Bilogrevic, Eleanor, Sáenz-Navajas, María Pilar
مصطلحات موضوعية: conceptualisation, favourable conditions, Languedoc-Roussillon, Northern Rhone Valley, peppery notes, Rotundone
وصف الملف: application/pdf
Relation: info:eu-repo/semantics/altIdentifier/pissn/2494-1271; How do Syrah winemakers from two different French regions conceptualise peppery wines?, 2024, vol. 58, núm. 1; https://investigacion.unirioja.es/documentos/65e42341795b6b1f94c9b72e; urn:issn:2494-1271
-
15Academic Journal
المؤلفون: Clíona M. McCarthy, Kevin L. McKevitt, Sinéad A. Connolly, Isabel Andersson, Fiona C. Leahy, Siobhan Egan, Michael A. Moloney, Eamon G. Kavanagh, Colin Peirce, Eoghan M. Cunnane, Kieran D. McGourty, Michael T. Walsh, John J. E. Mulvihill
مصطلحات موضوعية: Medicine, Physiology, Biotechnology, Evolutionary Biology, Cancer, Inorganic Chemistry, Virology, Space Science, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, optimised mounting condition, fresh biological tissues, 3d biomimetic models, tissue slice mounting, mitigate tissue degradation, fresh biological tissue, rapid tissue sectioning,
+microindentation%22">xlink "> microindentation, tissue must first, fresh tissue slices, embedding tissue, rapid processing, tear easily, protocol allows, processed rapidly, precisely sectioned, favourable method, challenges exist, accurately represent -
16Academic Journal
المؤلفون: Clíona M. McCarthy, Kevin L. McKevitt, Sinéad A. Connolly, Isabel Andersson, Fiona C. Leahy, Siobhan Egan, Michael A. Moloney, Eamon G. Kavanagh, Colin Peirce, Eoghan M. Cunnane, Kieran D. McGourty, Michael T. Walsh, John J. E. Mulvihill
مصطلحات موضوعية: Medicine, Physiology, Biotechnology, Evolutionary Biology, Cancer, Inorganic Chemistry, Virology, Space Science, Biological Sciences not elsewhere classified, Mathematical Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, optimised mounting condition, fresh biological tissues, 3d biomimetic models, tissue slice mounting, mitigate tissue degradation, fresh biological tissue, rapid tissue sectioning,
+microindentation%22">xlink "> microindentation, tissue must first, fresh tissue slices, embedding tissue, rapid processing, tear easily, protocol allows, processed rapidly, precisely sectioned, favourable method, challenges exist, accurately represent -
17Academic Journal
المؤلفون: H.G. Gowtham, Prasanna D. Revanasiddappa, Mahadevamurthy Murali, Sudarshana Brijesh Singh, M.R. Abhilash, Sushma Pradeep, Chandan Shivamallu, Raghu Ram Achar, Ekaterina Silina, Victor Stupin, Natalia Manturova, Ali A. Shati, Mohammad Y. Alfaifi, Serag Eldin I. Elbehairi, Shiva Prasad Kollur
مصطلحات موضوعية: Biochemistry, Cell Biology, Biotechnology, Cancer, Biological Sciences not elsewhere classified, Chemical Sciences not elsewhere classified, Information Systems not elsewhere classified, present study explores, higher gastrointestinal absorption, favourable logbb value, egg model predicted, div >< p, central nervous system, active binding site, >., herg toxicity, 100 ns revealed, threshold docking score, possessed significant efficacy, computational studies concluded, binding egfr ’, 200 metabolites screened, known standard inhibitor, stable complex formation, active sites compared, standard egfr inhibitor, molecular docking confirmed, md simulation analysis, standard inhibitor, stable complex
-
18Academic Journal
المؤلفون: Vázquez Medina, Rubén, Parras Berrocal, Iván Manuel, Koseki, S., Cabos, W., Sein, D.V, Izquierdo González, Alfredo
المساهمون: Física Aplicada
المصدر: Science of the Total Environment, Vol. 898, 2023
مصطلحات موضوعية: Climate change, Coastal upwelling, Ocean stratification, Regional climate system model, Upwelling favourable winds, Upwelling source water depth
وصف الملف: application/pdf
Relation: info:eu-repo/grantAgreement/AEI/Plan Estatal de Investigación Científica y Técnica y de Innovación 2017-2020/RTI2018-100865-B-C22/ES/CIRCULACION Y PROCESOS DE TRANSPORTE EN LOS ESTUARIOS DEL GOLFO DE CADIZ: SITUACION ACTUAL Y/; info:eu-repo/grantAgreement/AEI//PID2021-128656OB-I00; http://hdl.handle.net/10498/31722
-
19Academic Journal
المؤلفون: A. A. Rumyantsev, А. А. Румянцев
المصدر: Meditsinskiy sovet = Medical Council; № 22 (2023); 80-86 ; Медицинский Совет; № 22 (2023); 80-86 ; 2658-5790 ; 2079-701X
مصطلحات موضوعية: ниволумаб, IMDC, MSKCC, favourable prognosis, sunitinib, pazopanib, pembrolizumab, axitinib, lenvatinib, cabozantinib, nivolumab, благоприятный прогноз, сунитиниб, пазопаниб, пембролизумаб, акситиниб, ленватиниб, кабозантиниб
وصف الملف: application/pdf
Relation: https://www.med-sovet.pro/jour/article/view/7983/7070; Piao X-M, Byun YJ, Zheng C-M, Song SJ, Kang HW, Kim WT et al. A New Treatment Landscape for RCC: Association of the Human Microbiome with Improved Outcomes in RCC. Cancers. 2023;15(3):935. https://doi.org/10.3390/cancers15030935.; Волкова МИ, Алексеев БЯ, Гладков ОА, Матвеев ВБ, Носов ДА. Практические рекомендации по лекарственному лечению почечноклеточного рака. Злокачественные опухоли. 2022;12(3s2-1):579–588. https://doi.org/10.18027/2224-5057-2022-12-3s2-579-588.; Rathmell WK, Rumble RB, Van Veldhuizen PJ, Al-Ahmadie H, Emamekhoo H, Hauke RJ et al. Management of Metastatic Clear Cell Renal Cell Carcinoma: ASCO Guideline. J Clin Oncol. 2022;40(25):2957–2995. https://doi.org/10.1200/JCO.22.00868.; Ljungberg B, Albiges L, Abu-Ghanem Y, Bedke J, Capitanio U, Dabestani S et al. European Association of Urology Guidelines on Renal Cell Carcinoma: The 2022 Update. Eur Urol. 2022;82(4):399–410. https://doi.org/10.1016/j.eururo.2022.03.006.; Atkins MB, Plimack ER, Puzanov I, Fishman MN, McDermott DF, Cho DC et al. Axitinib in combination with pembrolizumab in patients with advanced renal cell cancer: a non-randomised, open-label, dose-finding, and dose-expansion phase 1b trial. Lancet Oncol. 2018;19(3):405–415. https://doi.org/10.1016/S1470-2045(18)30081-0.; Rini BI, Plimack ER, Stus V, Gafanov R, Hawkins R, Nosov D et al. Pembrolizumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma. N Engl J Med. 2019;380(12):1116–1127. https://doi.org/10.1056/NEJMoa1816714.; Rini BI, Plimack ER, Stus V, Gafanov R, Waddell T, Nosov D et al. Pembrolizumab plus axitinib versus sunitinib as first-line therapy for advanced clear cell renal cell carcinoma: 5-year analysis of KEYNOTE-426. J Clin Oncol. 2023;41(17 Suppl.):LBA4501. https://doi.org/10.1200/JCO.2023.41.17_suppl.LBA4501.; Powles T, Plimack ER, Soulières D, Waddell T, Stus V, Gafanov R et al. Pembrolizumab plus axitinib versus sunitinib monotherapy as first-line treatment of advanced renal cell carcinoma (KEYNOTE-426): extended follow-up from a randomised, open-label, phase 3 trial. Lancet Oncol. 2020;21(12):1563–1573. https://doi.org/10.1016/S1470-2045(20)30436-8.; Plimack ER, Powles T, Stus V, Gafanov R, Nosov D, Waddell T et al. Pembrolizumab Plus Axitinib Versus Sunitinib as First-line Treatment of Advanced Renal Cell Carcinoma: 43-month Follow-up of the Phase 3 KEYNOTE-426 Study. Eur Urol. 2023;84(5):449–454. https://doi.org/10.1016/j.eururo.2023.06.006.; Grünwald V, Powles T, Choueiri TK, Hutson TE, Porta C, Eto M et al. Lenvatinib plus everolimus or pembrolizumab versus sunitinib in advanced renal cell carcinoma: study design and rationale. Future Oncol. 2019;15(9):929–941. https://doi.org/10.2217/fon-2018-0745.; Motzer R, Alekseev B, Rha S-Y, Porta C, Eto M, Powles T et al. Lenvatinib plus Pembrolizumab or Everolimus for Advanced Renal Cell Carcinoma. N Engl J Med. 2021;384(14):1289–1300. https://doi.org/10.1056/NEJMoa2035716.; Choueiri TK, Eto M, Motzer R, De Giorgi U, Buchler T, Basappa NS et al. Lenvatinib plus pembrolizumab versus sunitinib as first-line treatment of patients with advanced renal cell carcinoma (CLEAR): extended follow-up from the phase 3, randomised, open-label study. Lancet Oncol. 2023;24(3):228–238. https://doi.org/10.1016/S1470-2045(23)00049-9.; Motzer RJ, Porta C, Eto M, Powles T, Grünwald V, Hutson TE et al. Final prespecified overall survival (OS) analysis of CLEAR: 4-year follow-up of lenvatinib plus pembrolizumab (L+P) vs sunitinib (S) in patients (pts) with advanced renal cell carcinoma (aRCC). J Clin Oncol. 2023;41(16 Suppl.):4502. https://doi.org/10.1200/JCO.2023.41.16_suppl.4502.; Grünwald V, Powles T, Kopyltsov E, Kozlov V, Alonso-Gordoa T, Eto M et al. Survival by Depth of Response and Efficacy by International Metastatic Renal Cell Carcinoma Database Consortium Subgroup with Lenvatinib Plus Pembrolizumab Versus Sunitinib in Advanced Renal Cell Carcinoma: Analysis of the Phase 3 Randomized CLEAR Study. Eur Urol Oncol. 2023;6(4):437–446. https://doi.org/10.1016/j.euo.2023.01.010.; Grünwald V, Powles T, Eto M, Kopyltsov E, Rha SY, Porta C et al. Phase 3 CLEAR study in patients with advanced renal cell carcinoma: outcomes in subgroups for the lenvatinib-plus-pembrolizumab and sunitinib arms. Front Oncol. 2023;13:1223282. https://doi.org/10.3389/fonc.2023.1223282.; Motzer RJ, Penkov K, Haanen J, Rini B, Albiges L, Campbell MT et al. Avelumab plus Axitinib versus Sunitinib for Advanced Renal-Cell Carcinoma. N Engl J Med. 2019;380(12):1103–1115. https://doi.org/10.1056/NEJMoa1816047.; Choueiri TK, Motzer RJ, Rini BI, Haanen J, Campbell MT, Venugopal B et al. Updated efficacy results from the JAVELIN Renal 101 trial: first-line avelumab plus axitinib versus sunitinib in patients with advanced renal cell carcinoma. Ann Oncol. 2020;31(8):1030–1039. https://doi.org/10.1016/j.annonc.2020.04.010.; Haanen JBAG, Larkin J, Choueiri TK, Albiges L, Rini BI, Atkins MB et al. Extended follow-up from JAVELIN Renal 101: subgroup analysis of avelumab plus axitinib versus sunitinib by the International Metastatic Renal Cell Carcinoma Database Consortium risk group in patients with advanced renal cell carcinoma. ESMO Open. 2023;8(3):101210. https://doi.org/10.1016/j.esmoop.2023.101210.; Choueiri TK, Powles T, Burotto M, Escudier B, Bourlon MT, Zurawski B et al. Nivolumab plus Cabozantinib versus Sunitinib for Advanced Renal-Cell Carcinoma. N Engl J Med. 2021;384(9):829–841. https://doi.org/10.1056/NEJMoa2026982.; Motzer RJ, Powles T, Burotto M, Escudier B, Bourlon MT, Shah AY et al. Nivolumab plus cabozantinib versus sunitinib in first-line treatment for advanced renal cell carcinoma (CheckMate 9ER): long-term follow-up results from an open-label, randomised, phase 3 trial. Lancet Oncol. 2022;23(7):888–898. https://doi.org/10.1016/S1470-2045(22)00290-X.; Burotto M, Powles T, Escudier B, Apolo AB, Bourlon MT, Shah AY et al. Nivolumab plus cabozantinib vs sunitinib for first-line treatment of advanced renal cell carcinoma (aRCC): 3-year follow-up from the phase 3 CheckMate 9ER trial. J Clin Oncol. 2023;41(6 Suppl.):603. https://doi.org/10.1200/JCO.2023.41.6_suppl.603.; Quhal F, Mori K, Fajkovic H, Remzi M, Shariat SF, Schmidinger M. Immunotherapy-based combinations in the first-line treatment of metastatic renal cell carcinoma with sarcomatoid features: a systematic review and network meta-analysis. Curr Opin Urol. 2022;32(1):61–68. https://doi.org/10.1097/MOU.0000000000000940.; Buti S, Bersanelli M, Mazzaschi G, Cattrini C, Brunelli M, Maio MD. Can we identify a preferred first-line strategy for sarcomatoid renal cell carcinoma? A network meta-analysis. Immunotherapy. 2022;14(2):145–153. https://doi.org/10.2217/imt-2021-0157.; Hou M, Xing H, He S, Yang X, Peng D, Li Y et al. The Predictive Value of Three Variables in Patients with Metastatic Renal Cell Carcinoma Treated with Immune-Based Combination Therapies in Randomized Clinical Trials: A Systematic Review and Meta-Analysis. J Oncol. 2022;2022:7733251. https://doi.org/10.1155/2022/7733251.; Aldin A, Besiroglu B, Adams A, Monsef I, Piechotta V, Tomlinson E et al. First-line therapy for adults with advanced renal cell carcinoma: a systematic review and network meta-analysis. Cochrane Database Syst Rev. 2023;5(5):CD013798. https://doi.org/10.1002/14651858.CD013798.pub2.; Collinson FJ, Gregory WM, McCabe C, Howard H, Lowe C, Potrata D et al. The STAR trial protocol: a randomised multi-stage phase II/III study of Sunitinib comparing temporary cessation with allowing continuation, at the time of maximal radiological response, in the first-line treatment of locally advanced/metastatic Renal Cancer. BMC Cancer. 2012;12(1):598. https://doi.org/10.1186/1471-2407-12-598.; Brown JE, Royle K-L, Gregory W, Ralph C, Maraveyas A, Din O et al. Temporary treatment cessation versus continuation of first-line tyrosine kinase inhibitor in patients with advanced clear cell renal cell carcinoma (STAR): an open-label, non-inferiority, randomised, controlled, phase 2/3 trial. Lancet Oncol. 2023;24(3):213–227. https://doi.org/10.1016/S1470-2045(22)00793-8.; Parikh M, Lara PN. Evaluating the Optimal Duration of Immunotherapy in Kidney Cancer. Kidney Cancer. 2022;6(2):105–107. https://doi.org/10.3233/KCA-229003.; Tzeng A, Tzeng TH, Ornstein MC. Treatment-free survival after discontinuation of immune checkpoint inhibitors in metastatic renal cell carcinoma: a systematic review and meta-analysis. J Immunother Cancer. 2021;9(10):e003473. https://doi.org/10.1136/jitc-2021-003473.; https://www.med-sovet.pro/jour/article/view/7983
-
20Academic Journal
المؤلفون: Mia, Md Abu Touhid, Islam, Md Rafiquel, Ali, Md Sekender, Roy, Ranjan
المصدر: SAARC Journal of Agriculture; Vol. 22 No. 1 (2024); 243-255 ; 2312-8038 ; 1682-8348
مصطلحات موضوعية: CSA, attitude, coastal farmers, favourable
Time: Bangladesh
وصف الملف: application/pdf